Harbourvest Partners LLC / RLAY
Harbourvest Partners LLC’s Relay Therapeutics Inc Position
Does Harbourvest Partners LLC own Relay Therapeutics Inc (RLAY)? Not currently — the last reported position was 296.4K shares worth $1M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$1M
Q2 2025
Shares
296.4K
% of Portfolio
+1.12%
Quarters Held
18
position exited
Position History RLAY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 296.4K | $1M | +1.12% |
| Q1 2025 | 296.4K | $776,573 | +0.51% |
| Q4 2024 | 296.4K | $1M | +0.60% |
| Q3 2024 | 296.4K | $2M | +1.09% |
| Q2 2024 | 296.4K | $2M | +1.03% |
| Q1 2024 | 296.4K | $2M | +1.12% |
| Q4 2023 | 296.4K | $3M | +1.09% |
| Q3 2023 | 296.4K | $2M | +0.85% |
| Q2 2023 | 296.4K | $4M | +1.06% |
| Q1 2023 | 296.4K | $5M | +1.64% |
| Q4 2022 | 296.4K | $4M | +1.48% |
| Q3 2022 | 296.4K | $7M | +2.17% |
| Q2 2022 | 296.4K | $5M | +1.63% |
| Q1 2022 | 296.4K | $9M | +1.81% |
| Q4 2021 | 296.4K | $9M | +1.16% |
| Q3 2021 | 296.4K | $9M | +0.88% |
| Q2 2021 | 296.4K | $11M | +1.04% |
| Q1 2021 | 296.4K | $10M | +1.37% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Harbourvest Partners LLC’s full portfolio or all institutional holders of RLAY.